ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Physical Activity and Inactivity in Lung Cancer Survivors

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators: Memorial Sloan-Kettering Cancer Center
National Institutes of Health (NIH)
Information provided by: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00582348
  Purpose

The purpose of this study is to learn how often lung cancer survivors exercise. We also want to learn what helps people to be active or prevents them from being active. Learning this will help us to expand services for lung cancer survivors.


Condition
Lung Cancer Survivors

MedlinePlus related topics:   Cancer    Lung Cancer   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Case-Only, Retrospective
Official Title:   Physical Activity and Inactivity in Lung Cancer Survivors

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • The primary outcomes of this study are physical activity levels and preferences regarding physical activity counseling and interventions [ Time Frame: 45-60 minutes ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment:   200
Study Start Date:   September 2005
Estimated Study Completion Date:   September 2010
Estimated Primary Completion Date:   September 2010 (Final data collection date for primary outcome measure)

Detailed Description:

Despite the potential benefits of physical activity, particularly for cancer survivors with comorbid pulmonary and cardiac conditions, no previous research has examined the physical activity levels of lung cancer survivors, an underrepresented subpopulation in cancer survivorship research. We address this research gap in the current study, in which a random sample of 200 lung cancer survivors will complete a comprehensive telephone interview or use self-report to complete a questionnaire focusing on physical activity, related covariates, and preferences regarding physical activity counseling and interventions. We estimate the total time for the completion of the interview or self-report questionnaire to be 45-60 minutes. This study will be conducted with survivors of primary lung cancer who are from 1 to 5 years posttreatment and were treated at Memorial Sloan-Kettering Cancer Center (MSKCC).

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample

Study Population

Eligible lung cancer survivors will be identified by the Thoracic DMT Data Manager from the Thoracic Surgical Database.


Criteria

Inclusion Criteria:

  • Diagnosis of primary Stage IA or IB NSCLC;
  • Underwent surgical resection for NSCLC at MSKCC;
  • From 1 to 5 years post-treatment for NSCLC prior to study recruitment;
  • No evidence of disease (NED) at the time of recruitment;
  • Can be reached by telephone;
  • Able to provide informed consent.

Exclusion Criteria:

  • Undergoing active antineoplastic treatment;
  • Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00582348

Locations
United States, New York
Memorial Sloan-Kettering Cancer Center    
      New York, New York, United States, 10065

Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
National Institutes of Health (NIH)

Investigators
Principal Investigator:     Jamie Ostroff, PhD     Memorial Sloan-Kettering Cancer Center    
  More Information


Memorial Sloan-Kettering Cancer Center website  This link exits the ClinicalTrials.gov site
 

Responsible Party:   Memorial Sloan-Kettering Cancer Center ( Jamie Ostroff, PhD )
Study ID Numbers:   05-094, Grant # CA115212
First Received:   December 21, 2007
Last Updated:   June 5, 2008
ClinicalTrials.gov Identifier:   NCT00582348
Health Authority:   United States: Food and Drug Administration

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Lung Cancer  
Survivor  
Lung  

Study placed in the following topic categories:
Thoracic Neoplasms
Respiratory Tract Diseases
Lung Neoplasms
Lung Diseases

Additional relevant MeSH terms:
Respiratory Tract Neoplasms
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on October 31, 2008




Links to all studies - primarily for crawlers